Skip to content

MRI study of neuromelanin imaging with different acceleration modalities and sequences

MRI study of neuromelanin imaging with different acceleration modalities and sequences

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099113
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-03-29
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group of Parkinson's disease patients:None
The best sequence test group for normal population:None
The test group of the optimal acceleration method for the normal population:None

Sponsors

Affiliated Kangning Hospital of Ningbo University (Ningbo Kangning Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for Normal Population: 1. Age range: 10-100 years old. 2. No history of neurological diseases (such as Parkinson's disease, Alzheimer's disease, stroke, etc.). 3. No history of mental illness (such as depression, schizophrenia, etc.). 4. No history of severe head trauma or brain surgery. 5. No contraindications to magnetic resonance imaging (MRI) (such as metal implants in vivo, claustrophobia, etc.). 6. Able to cooperate with the completion of MRI examination. 7. Sign the informed consent form (if the subject is a minor, the guardian must sign it). Inclusion Criteria for Patients with Parkinson's Disease: 1. Age range: 10-100 years old. 2. Meet internationally recognized diagnostic criteria for Parkinson's disease (such as British Brain Bank Criteria or MDS Diagnostic Criteria). 3. The condition is stable, and there is no obvious fluctuation (such as end-of-dose phenomenon, switch phenomenon, etc.). 4. No other neurological diseases (such as Alzheimer's disease, stroke, etc.). 5. No history of mental illness (such as depression, schizophrenia, etc.). 6. No history of severe head trauma or brain surgery. 7. No contraindications to MRI examination. 8. Able to cooperate with MRI examination. 9. Sign the informed consent form (if the subject is a minor, the guardian must sign it).

Exclusion criteria

Exclusion criteria: Normal Population Exclusion Criteria: 1. Presence of a diagnosis or symptom of a neurological disorder or psychiatric disorder. 2. Have a history of severe head trauma or brain surgery. 3. There are contraindications to MRI examination. 4. Recent (e.g., within 6 months) use of drugs that may affect neuromelanin signaling (such as antipsychotic drugs, antiparkinson's disease drugs, etc.). 5. Pregnant or lactating females. 6. Unable to cooperate with the completion of MRI examination. 7. Refusal to sign informed consent. Exclusion Criteria for Patients with Parkinson's Disease: 1. Does not meet the diagnostic criteria for Parkinson's disease. 2. Presence of other neurological diseases or psychiatric disorders. 3. Have a history of severe head trauma or brain surgery. 4. There are contraindications to MRI examination. 5. Recent (e.g., within 6 months) treatment that may affect neuromelanin signaling (e.g., deep brain stimulation surgery). 6. Pregnant or lactating females. 7. Unable to cooperate with the completion of MRI examination. 8. Refusal to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Contrast;

Countries

China

Contacts

Public ContactYao Gang

Affiliated Kangning Hospital of Ningbo University

yaogang0303@126.com+86 135 6784 3667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026